BP Shares Decline After Board Ousts Chairman Albert Manifold Over Serious Conduct Issues Yardeni Warns New Fed Chair May Need to Raise Rates in July to Calm Bond Vigilantes Financial Times Bond Markets Remain Too Complex for Many Investors With Five Key Pitfalls to Avoid Markets at Crossroads Axis AMCs Hitesh Zaveri on Consolidation Largecaps vs Smallcaps and IT Stocks World Bank Data Suggests Automation Could Threaten 69 of Jobs in India Could Peace Talks Over Strait of Hormuz Reshape Global Oil Markets Petraeus Weighs In IMMR Q3 2025 Earnings EPS Surges Past Estimates as Haptic Licensing Gains Momentum ELBM Q4 2025 Earnings Significant EPS Miss as PreRevenue Company Navigates Development Phase vTv Therapeutics Q1 2026 Earnings Strong EPS Surprise Driven by NonOperating Items Stock Declines BNS Q1 2026 Earnings EPS Beats Estimates by Nearly 4 as Bank Delivers Solid Results SNDL Q1 2026 Earnings EPS Beats Estimates as Loss Narrows Western Union WU Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Shares Slide Lakeside Holding Limited LSH Holds Steady at 058 as Rangebound Trading Persists Sizzle Acquisition Corp II SZZL Holds Steady Near Support in Quiet Trading Session DTE Energy Junior Subordinated Debentures DTW Hold Steady as Interest Rate Uncertainty Lingers Honda Motor HMC Edges Higher as Support Holds Firm Antelope Enterprise Holdings AEHL Falters as Selling Pressure Mounts US Stock Futures Bond Yields Decline After Reports Putin Updated Nuclear Doctrine Medicare Part B Premiums Poised for Sharp Increase in 2026 Following 2024 Asset Sale Strive Asset Management Expands Bitcoin Holdings to 16500 Tokens Pope Leos Encyclical Criticizes AI as Instrument of Domination Exclusion and Death Anthropic Present at Signing T1 Energy TE Surges Over 42 as Analyst Optimism Outweighs ShortSeller Concerns US Shale Producers Gradually Increase Output with Capital Discipline US Payrolls Beat Expectations in April but Underlying Weaknesses Raise Concerns ARR Q1 2026 Earnings EPS Beats Estimates Amidst a Choppy Rate Environment Teva Pharmaceuticals Advances 235 as Buyers Test Resistance Near 37